In summary we have shown that HCMV establishes latent infection of huBLT mice resulting in the generation of both human CD4+ and CD8+ T-cell responses as well as HCMV neutralizing IgM and IgG neutralizing antibodies. The gene discussed is CD8A; the disease is disease arising from reactivation of latent virus.